Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists. - Wikidata - awgldk - TriplyDB

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists.

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists.

http://www.wikidata.org/entity/Q37905606

about

Science gone translational: the OX40 agonist story Human prostatic acid phosphatase: structure, function and regulation.Emerging roles of human prostatic Acid phosphatase Symmetry-Directed Design of Protein Cages and Protein Lattices and Their Applications.

P2860

Q27022436-9E5498D6-8462-4D03-A17F-6A10ADB965EB Q36913762-EBCFC319-5004-45E3-91D1-1F37C1503C5D Q37145460-5F3FD549-CEC8-4A37-99B8-953387240330 Q40303265-838E15CF-5AC9-4C6E-99F1-E3E587C25BC9

P2860

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists.

http://www.wikidata.org/entity/Q37905606

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@en

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@nl

type

label

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@en

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@nl

prefLabel

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@en

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@nl

P1433

Q37905606-130E4EDB-3F86-4809-9D54-BDB098A1593B

P1476

Q37905606-A70C9783-CBC6-4276-AA87-242A429F7AB3

P2093

Q37905606-938BA530-4AA8-486C-A560-7C9B88D03579

P2860

Q37905606-02A3C019-37A8-4ED1-93D9-EA3FCBCAE42F

Q37905606-05D22390-4B11-4EDE-97E0-0C57458A3C2B

Q37905606-2E3E1737-9847-4355-B310-570AFABAFE5D

Q37905606-3E338572-F6B2-4805-BD3E-2F98E5589993

Q37905606-406DF899-97D0-4CD3-93DA-ABDB5047327B

Q37905606-4AC57273-873E-42B3-8A17-66436170C030

Q37905606-57449DF5-F7DC-4ADE-B687-521DE77EE2AF

Q37905606-58E1A901-6FBF-4375-BA22-6509A1FC27A2

Q37905606-5B481561-BB0A-4A98-B8E3-403AE79C0438

Q37905606-75CF7914-59C1-4003-AD03-D56781A1786C

P304

Q37905606-F4D93E0E-DB3C-4FC8-ACE0-D0C776EAA329

P31

Q37905606-EEF55A9F-231D-4C37-9C72-E2CDBAD4AE03

P356

Q37905606-6E784873-EA44-42D9-B24A-13B907CAF217

P433

Q37905606-24FAEDA3-9026-45C0-B83B-019CED8C4623

P478

Q37905606-A03AF884-AFB9-4EEB-9ADF-097921EE52EA

P577

Q37905606-4EBA03C2-75E3-4CA9-AA77-3FE116C6F53B

P5875

Q37905606-B62D7D39-6CE1-4B85-987D-EC559303741C

P698

Q37905606-5F654103-C1C2-4BBC-BDE9-A3FCF43AF30E

P932

Q37905606-56952897-8D47-4862-A1F8-75E15E0340DC

P356

1758834010397692

P1433

Therapeutic advances in medical oncology

P1476

Sipuleucel-T in patients with ...... r: an insight for oncologists.

@en

P2093

Jorge A Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

The dendritic cell system and its role in immunogenicity

Autoantibody signatures in prostate cancer.

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

A novel hybridoma antibody (PASE/4LJ) to human prostatic acid phosphatase suitable for immunohistochemistry.

P304

101-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834010397692

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51521200

http://www.w3.org/2001/XMLSchema#string

P698

21789160

http://www.w3.org/2001/XMLSchema#string

P932

3126040

http://www.w3.org/2001/XMLSchema#string